News

Biggest change to treatment of RA since the introduction of biologics in the early 2000s

Last month we brought you the news about the Draft Final decision from NICE regarding treatment of ‘moderate active’ RA with some advanced therapies and we’re now delighted to say that as of 14th July this is now Final Guidance. This is an incredible achievement after years of campaigning and has the potential to improve […]

News, 05 Jul

NRAS launch the #DoThe20Challenge to celebrate 20 years

This challenge has now closed. Thank you to everyone who participated and helped raise funds! To celebrate our 20th Anniversary, we have launched #DoThe20Challenge, a fun way supporters can celebrate with us! There are a lot of ideas to get you started, anything that involves the number 20 – are you ready to take on the challenge? […]

News, 21 Jan

NICE offers hope for thousands who until now, potentially faced a life of disability and pain

The National Institute for Health & Care Excellence (NICE) today released the Final Appraisal Document (FAD) on a new JAK inhibitor* filgotinib (Jyseleca) used in the treatment of Rheumatoid Arthritis (RA). NRAS warmly welcomes the fact that the FAD confirms that this drug will be available to not just to those most severely affected by […]

News, 02 Jan

NRAS report on the impact of living with active RA but not being able to access advanced therapies

In 2020, NRAS conducted a survey amongst its members and non-members who had RA with a disease duration more than 2 years, who were not on advanced therapies (i.e. biologic/biosimilar or targeted synthetic DMARDs (JAK inhibitors)), with the aim of revealing the everyday impact of living with RA in people not treated with advanced therapies. It […]

News, 14 Oct

Review published in ‘Musculoskeletal Care’ with contribution from NRAS

Just published in ‘Musculoskeletal Care’ – The Value, impact and role of nurses in rheumatology outpatient care: Critical review of the literature. 14/10/2020 Click here to read that review The Conclusion of this review: There is a convincing case to maintain and extend the role of nurses in managing RA, but further work is needed on […]

News, 10 Mar

EULAR issue new guidelines for the management of RA

The European League Against Rheumatism (EULAR) have issued updated guidelines on the management of RA, which had previously been updated in 2016.

News, 23 Jan

Important Statement from NRAS about access to medicines

For some time, NRAS has been concerned that some Clinical Commissioning Groups (CCGs) have been artificially restricting access to advanced therapies (biologics, biosimilars/JAK inhibitors) and undertook a Freedom of Information request to all CCGs about this.

News, 04 Nov

Congratulations to the Healthcare Champions of 2019

On 1st November, NRAS held its 6th Healthcare Champion awards ceremony in the magnificent surroundings of the Leathersellers’ Livery Hall in London.

News, 11 Oct

Shaping the Rheumatology Service in Scotland Scottish Quality Registry (ScotQR) for Rheumatoid Arthritis

People with RA will be interested to know about a new initiative very soon to be trialled in two areas of Scotland, NHS Greater Glasgow and Clyde and NHS Lanarkshire.